Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

A. Ari Hakimi,Martin H. Voss,Fengshen Kuo,Andrew W. Silagy,Mahtab Marker,Albert Reising,John M. Millholland,Timothy A. Chan,Paul Russo,Robert J. Motzer

Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

2020

A. Ari Hakimi
Martin H. Voss
Fengshen Kuo
Andrew W. Silagy
Mahtab Marker
Albert Reising
John M. Millholland
Timothy A. Chan
Paul Russo
Robert J. Motzer

5082Background: Defined stromal and immune features of the tumor microenvironment (TME) have proven relevant for outcomes with systemic therapy in advanced clear cell renal cell carcinoma (ccRCC). ...

Keywords:

Angiogenesis
Oncology
Nephrectomy
immune infiltration
Pathology
Internal medicine
Medicine
Placebo
Transcriptome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations